These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 24294355

  • 21. Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies.
    Kirsch R, Clarkson V, Shephard EG, Marais DA, Jaffer MA, Woodburne VE, Kirsch RE, Hall Pde L.
    J Gastroenterol Hepatol; 2003 Nov; 18(11):1272-82. PubMed ID: 14535984
    [Abstract] [Full Text] [Related]

  • 22. Nifedipine prevents hepatic fibrosis in a non-alcoholic steatohepatitis model induced by an L-methionine-and choline-deficient diet.
    Nakagami H, Shimamura M, Miyake T, Shimosato T, Minobe N, Moritani T, Kiomy Osako M, Nakagami F, Koriyama H, Kyutoku M, Shimizu H, Katsuya T, Morishita R.
    Mol Med Rep; 2012 Jan; 5(1):37-40. PubMed ID: 21946918
    [Abstract] [Full Text] [Related]

  • 23. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP, Stone WC, Karaca FG, Syn WK, Pereira TA, Agboola KM, Omenetti A, Jung Y, Teaberry V, Choi SS, Guy CD, Pollard J, Charlton P, Diehl AM.
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [Abstract] [Full Text] [Related]

  • 24. Methionine- and choline-deficient diet induces hepatic changes characteristic of non-alcoholic steatohepatitis.
    Marcolin E, Forgiarini LF, Tieppo J, Dias AS, Freitas LA, Marroni NP.
    Arq Gastroenterol; 2011 Nov; 48(1):72-9. PubMed ID: 21537547
    [Abstract] [Full Text] [Related]

  • 25. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice.
    McCuskey RS, Ito Y, Robertson GR, McCuskey MK, Perry M, Farrell GC.
    Hepatology; 2004 Aug; 40(2):386-93. PubMed ID: 15368443
    [Abstract] [Full Text] [Related]

  • 26. Nicotinic alpha-7 acetylcholine receptor deficiency exacerbates hepatic inflammation and fibrosis in a mouse model of non-alcoholic steatohepatitis.
    Kimura K, Inaba Y, Watanabe H, Matsukawa T, Matsumoto M, Inoue H.
    J Diabetes Investig; 2019 May; 10(3):659-666. PubMed ID: 30369082
    [Abstract] [Full Text] [Related]

  • 27. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.
    Velayudham A, Dolganiuc A, Ellis M, Petrasek J, Kodys K, Mandrekar P, Szabo G.
    Hepatology; 2009 Mar; 49(3):989-97. PubMed ID: 19115316
    [Abstract] [Full Text] [Related]

  • 28. Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor.
    Aljobaily N, Krutsinger K, Viereckl MJ, Joly R, Menlove B, Cone B, Suppes A, Han Y.
    Nutrients; 2022 Dec 30; 15(1):. PubMed ID: 36615835
    [Abstract] [Full Text] [Related]

  • 29. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice.
    Csak T, Velayudham A, Hritz I, Petrasek J, Levin I, Lippai D, Catalano D, Mandrekar P, Dolganiuc A, Kurt-Jones E, Szabo G.
    Am J Physiol Gastrointest Liver Physiol; 2011 Mar 30; 300(3):G433-41. PubMed ID: 21233280
    [Abstract] [Full Text] [Related]

  • 30. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.
    Simon Y, Kessler SM, Gemperlein K, Bohle RM, Müller R, Haybaeck J, Kiemer AK.
    World J Gastroenterol; 2014 Dec 21; 20(47):17839-50. PubMed ID: 25548482
    [Abstract] [Full Text] [Related]

  • 31. Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice.
    Tomita K, Tamiya G, Ando S, Ohsumi K, Chiyo T, Mizutani A, Kitamura N, Toda K, Kaneko T, Horie Y, Han JY, Kato S, Shimoda M, Oike Y, Tomizawa M, Makino S, Ohkura T, Saito H, Kumagai N, Nagata H, Ishii H, Hibi T.
    Gut; 2006 Mar 21; 55(3):415-24. PubMed ID: 16174657
    [Abstract] [Full Text] [Related]

  • 32. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
    Wei G, An P, Vaid KA, Nasser I, Huang P, Tan L, Zhao S, Schuppan D, Popov YV.
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan 01; 318(1):G174-G188. PubMed ID: 31630534
    [Abstract] [Full Text] [Related]

  • 33. Effects of treatment with hydrogen sulfide on methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats.
    Luo ZL, Tang LJ, Wang T, Dai RW, Ren JD, Cheng L, Xiang K, Tian FZ.
    J Gastroenterol Hepatol; 2014 Jan 01; 29(1):215-22. PubMed ID: 24117897
    [Abstract] [Full Text] [Related]

  • 34. Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet.
    Kassel KM, Guo GL, Tawfik O, Luyendyk JP.
    Lab Invest; 2010 Dec 01; 90(12):1794-804. PubMed ID: 20697377
    [Abstract] [Full Text] [Related]

  • 35. IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet.
    Luo XY, Takahara T, Kawai K, Fujino M, Sugiyama T, Tsuneyama K, Tsukada K, Nakae S, Zhong L, Li XK.
    Am J Physiol Gastrointest Liver Physiol; 2013 Dec 01; 305(12):G891-9. PubMed ID: 24136786
    [Abstract] [Full Text] [Related]

  • 36. Hepatoprotective Effect and Synergism of Bisdemethoycurcumin against MCD Diet-Induced Nonalcoholic Fatty Liver Disease in Mice.
    Kim SB, Kang OH, Lee YS, Han SH, Ahn YS, Cha SW, Seo YS, Kong R, Kwon DY.
    PLoS One; 2016 Dec 01; 11(2):e0147745. PubMed ID: 26881746
    [Abstract] [Full Text] [Related]

  • 37. Alanyl-Glutamine Protects Mice against Methionine- and Choline-Deficient-Diet-Induced Steatohepatitis and Fibrosis by Modulating Oxidative Stress and Inflammation.
    Hu J, Zheng Y, Ying H, Ma H, Li L, Zhao Y.
    Nutrients; 2022 Sep 15; 14(18):. PubMed ID: 36145172
    [Abstract] [Full Text] [Related]

  • 38. Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis.
    Galastri S, Zamara E, Milani S, Novo E, Provenzano A, Delogu W, Vizzutti F, Sutti S, Locatelli I, Navari N, Vivoli E, Caligiuri A, Pinzani M, Albano E, Parola M, Marra F.
    Clin Sci (Lond); 2012 Oct 15; 123(7):459-71. PubMed ID: 22545719
    [Abstract] [Full Text] [Related]

  • 39. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
    Farrell GC, Larter CZ, Hou JY, Zhang RH, Yeh MM, Williams J, dela Pena A, Francisco R, Osvath SR, Brooling J, Teoh N, Sedger LM.
    J Gastroenterol Hepatol; 2009 Mar 15; 24(3):443-52. PubMed ID: 19226377
    [Abstract] [Full Text] [Related]

  • 40. Hepatic vagus nerve regulates Kupffer cell activation via α7 nicotinic acetylcholine receptor in nonalcoholic steatohepatitis.
    Nishio T, Taura K, Iwaisako K, Koyama Y, Tanabe K, Yamamoto G, Okuda Y, Ikeno Y, Yoshino K, Kasai Y, Okuno M, Seo S, Sakurai T, Asagiri M, Hatano E, Uemoto S.
    J Gastroenterol; 2017 Aug 15; 52(8):965-976. PubMed ID: 28044208
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.